Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Buprenorphine-Assisted Opioid Discontinuation
NCT02737826Completed
- Sponsor
- Medical University of South Carolina
- Start
- May 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in opioid use disorder (OUD) comparing Gabapentin + Buprenorphine with Placebo + Buprenorphine (2 arms). Primary endpoints: Percentage of Patients Who Tolerate Buprenorphine Initiation and Number of Participants Who Achieve Opioid Cessation at 10 weeks. Started May 2016; status: completed.
02
Drugs
gabapentin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02737826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737826.